For instance, in a clinical phase I study launched by Westermann and colleagues, they immunized renal cell cancer (RCC) patients with IL-7 and CD80 genes cotransfected RCC tumor cells cancer vaccine (89). This evidence concerns the gene CD80 and renal cell adenocarcinoma.